2. INTRODUCTION
■ Bi-directional link
between CNS and
Enteric Nervous
System. [ENS]
■ Complex cross talk
between Endocrine
[HPA axis], Immune
[Cytokines,
Chemokines] and
Nervous System.
[ANS]
■ Microbiome plays a
pivotal role.
3. THE GUT
MICROBIOME
■ MICROBIOTA:
Microbe population within a specific ecosystem
of Host [Skin, oral, nasal, Gut, Genito-urinary].
Gut contains 1013 – 1014 microbiota
approximately.
10 times more than other cells of the human
body.
FERMICUTES & BACTEROIDES: comprises
75% of gut microbiota.
Disruption of Gut Microbiota: associated with
Allergy, Autoimmune Disorders, Metabolic
Disorders, Neurodegenerative Disorders,
Psychiatric Disorders.
4. THE GUT MICROBIOME CONTD.
■ MICROBIOME:
Collective Genetic material of all Microbiota residing on Host.
150 times> than Human Genome
Aptly called as Superorganisms.
Human Microbiome Project: Exploring symbiosis of
microbiome with host genome.
5. GUT-BRAIN LINK:
Starts during Intra-
Uterine period.
Exposure of Newborn
with maternal vaginal
microbiota during
childbirth.
Influence
Development &
Maturation of Human
CNS & ENS.
Interaction of Gut
Microbiota with Gut
mucosal Lining.
Tuning of developing
Immune System.
7. COMPONENTS
OF GUT BRAIN
AXIS CONTD.
1. VAGUS NERVE:
Most important part of
GBA.
Bi-directional modulator.
Through vagal spinal
afferents + Vagal sensory
neurons.
9. COMPONENTS OF
GUT BRAIN AXIS
CONTD.
2. NEUROACTIVE SUBSTANCES:
Important role in CNS modulation.
Serotonin, GABA, Tryptophan
metabolites are most common.
Synthesized and released by Gut
Microbiota.
Candida and Escherichia: tryptophan
metabolites
Bacillus: Dopamine
11. COMPONENTS OF GUT BRAIN AXIS
CONTD.
3. MICROBIOTA DERIVED METABOLITES
Significantly modify CNS Neuronal function & Fear
extinction Learning.
Mainly two metabolites:
1. Short Chain Fatty Acid.
2. Tryptophan Metabolite.
12. ■ SHORT CHAIN FATTY ACID
[SCFA]:
Through decomposition of fermentable
carbohydrate by gut microbiota.
Acetate, Propionate, Butyrate
Important role in Glucose Homeostasis,
reduction of Food intake, modulation of
lymphocytic function.
Through G-protein Coupled Receptor.
[GPCR]/ Epigenetic Modulator of Histone
Deacetylase.
Expressed in GUT, Muscle, Liver,
Pancreas, Adipocytes.
13. ■ TRYPTOPHAN METABOLITES:
Extensive role in cell cycles, mucosal barrier and immune
regulation.
Lactobacillus: Commonly identified to provide Indole
derivatives.
Person devoid of Tryptophan, catabolizing microbiota:
susceptible to colitis.
15. COMPONENTS OF GUT BRAIN AXIS
CONTD.
4. MICROBIOTA DERIVED PRODUCTS:
4 products:
1. LIPOPOLYSACCHARIDE [LPS]
2. LPS BINDING PROTEIN
3. PEPTIDOGLYCAN
4. FLAGELLIN
16. DEATH OF
GRAM –VE
BACTERIA
DESTRUCTION
OF CELL WALLS
RELEASEOF LPS,
RECOGNISED BY
TOLL LIKE
RECEPTOR 4,
EXPRESSEDOVER
IMMUNECELLS
INDUCE
CYTOKINE
PRODUCTION
LEAKY GUT
SYNDROME +
ANXIETY,
DEPRESSION,
MEMORY
IMPAIRMENT
LPS:
Most important
Bacterial endotoxin
17. COMPONENTS OF GUT BRAIN AXIS
CONTD.
5. ENTERO-ENDOCRINE CELLS
[EEC]
Represent only 1% of the epithelial
cells.
Scattered throughout the GI tract.
Release a variety of Gut Hormones in
response to diet related stimuli.
Prime importance in Gut motility,
Hormone release, appetite and
digestion.
18. COMPONENTS OF GUT
BRAIN AXIS CONTD.
6. GUT HORMONES
Mainly 4 hormones:
1. GHRELIN
2. CCK
3. GLP-1
4. GIP
19. ■ GHRELIN
Released from proximal A cells of stomach.
During food restriction.
FOOD
RESTRICTION/FASTI
NG, INCREASED
GHRELIN
RECEPTORON
VAGALAFFERENT
AND NODOSE
GANGLION
SIGNALSTO BRAIN
DIRECTLY CROSS
BBB
HYPOTHALAMUS
[FOOD
REGULATORY
CENTRE]
INDUCES FOOD
INTAKE, PROMOTE
MEMORY
REGULATION
BINDTO GROWTH
HORMONE
21. ■ GLP—1
[GLUCAGON LIKE
PEPTIDE]
Released from L cells
along with PYY [Peptide
YY]: mostly from Ileum
and Colon
Inhibitory effect on energy
intake, promotes satiety.
Widely distributed: Gut,
Kidney, Pancreas, Vagus
Nerve, Hypothalamus.
GLP-1 agonist: help to
treat DM.
24. GBA : NEUROLOGICALAND PSYCHIATRIC
DISORDERS:
Inflammatory hypothesis: Widely accepted in Depression, Anxiety
Also postulated in ASD, Neurodevelopmental Disorders, Schizophrenia,
Neurodegenerative Disorders like AD, PD, MS, ALS.
Considered as a Harbinger for newer/novel treatment modalities.